Neogen Chemicals Closes QIP, Allots 26.6 Lakh Shares at ₹2,255 Each
Neogen Chemicals Limited closed its QIP issue on September 16, 2026, allotting 26,60,753 equity shares at ₹2,255 per share. The QIP opened on September 10, 2026, and the funds raised will be used for the company's growth.
The QIP provides additional capital which can be used for expansion, debt reduction, or other strategic initiatives, potentially impacting the company's financial performance and growth trajectory.
The company successfully completed a Qualified Institutions Placement (QIP), indicating investor confidence and providing capital for future growth. The price achieved was also favorable.
Neogen Chemicals Limited has announced the outcome of its Fund-Raising Committee meeting held on September 16, 2026. The committee approved the closure of the Qualified Institutions Placement (QIP) issue period on the same day, following the receipt of application forms for 26,60,753 fully paid-up Equity Shares.
The issue, which opened on September 10, 2026, saw the determination and approval of the issue price at ₹2,255 per Equity Share, with a face value of ₹10 and a premium of ₹2,245 per share. This price was determined in consultation with the lead managers appointed for the issue.
The committee also approved and adopted the placement document dated September 16, 2026, in connection with the QIP. Furthermore, it approved the confirmation of allocation notes to be sent to eligible qualified institutional buyers, intimating them of the share allocation. The placement document will be filed with the BSE and NSE and is also available on the company's website.
What to do with a filing like this
Neogen Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Neogen Chemicals Limited. Read the original for the full detail.